Company intelligence / Profile preview
Edesa Biotech, Inc.
Markham, Ontario, Canadaedesabiotech.com ↗
- Ownership
- Public · EDSA
- Employees
- ~16
- Development stage
- Phase 2
01
Overview
Edesa Biotech has multiple late-stage product candidates targeting inflammatory and immune-related diseases. Its lead monoclonal antibody program for ARDS has advanced to Phase II/III trials with support from U.S. government studies. The company’s dermatology assets include a topical non-steroidal anti-inflammatory cream for allergic contact dermatitis that has completed Phase III studies and an anti-CXCL10 mAb in Phase II for vitiligo. Early results have shown statistically significant improvements in targeted symptoms in clinical studies of their dermatology asset EB01[6].
- Therapeutic areas
- PulmonologyDermatology
- Modalities
- Monoclonal antibodies (mAbs)Small molecule inhibitors (e.g., sPLA2 inhibitor)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
NovImmune SA – collaboration on monoclonal antibodies targeting TLR4 and CXCL10Yissum Research Development Company – development of products for dermal/gastrointestinal applications[4].
04
Financials
- Market cap
- $20.5M
- Total revenue
- $0
- Enterprise value
- $10.2M
Beyond the preview
Go deeper on Edesa Biotech, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Edesa Biotech, Inc..